Table 4.
Studies in which budesonide was found to be more cost-effective than placebo or other usual asthma therapy
| Ref. # | Study duration | Country |
Budesonide versus placebo |
Budesonide |
Placebo |
|
|---|---|---|---|---|---|---|
| Health care cost reduction (patient/yr) | Pvalue | Total costs (patient/yr) | Total costs (patient/yr) | |||
| 9 | 3 yrs | Australia | $21 | <0.05 | NA | NA |
| Sweden | $48 | 0.01 | ||||
| Canada | $44 | <0.1 | ||||
| 11 | 6 m | US | NA | NA | $3,828 | $5,180 |
| 18 | 6 m | US | NA | NA | BT 200 μg, n = 53, $11 BT 400 μg, n = 55, $9 BT 800 μg, n = 57, $18 |
$37 |
| 21 | 3 yrs | US | $11.30, Health care perspective $3.70, Societal perspective |
NA | NA | NA |
| 22 | 3 yrs | US | 192/3 yr | NA | NA | NA |
Notes: All currencies have been converted and inflated to year 2008. Yr = year(s).